WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...
A Cedars-Sinai study has identified a previously unknown role for astrocyte cells in how the brain responds to damage and ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an award of up to $856,250 from Breakthrough T1D, the leading global type 1 ...
Funding will accelerate development of manufactured pancreatic beta cells capable of restoring insulin production using Syntax’s Cellgorithm™ technology Syntax Bio, a synthetic biology company ...
The Science Advances publication details Cellgorithm™, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...
Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...
CAMBRIDGE, Mass., Oct. 29, 2025 /PRNewswire/ -- CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific ...
Scientist Kate Adamala doesn’t remember exactly when she realized her lab at the University of Minnesota was working on something potentially dangerous — so dangerous in fact that some researchers ...
🎨 Watch as I create mesmerizing acrylic pour and marbling art! From my first dirty pour to silk marbling, each piece comes alive with vibrant colors and flowing designs. Perfect for art lovers, DIY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback